Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PneumaCare Ltd logo — Pioneers of the technology – Structured Light Plethysmograph...

PneumaCare Ltd

Pioneers of the technology – Structured Light Plethysmography (SLP)

Founded 2009 United Kingdom United Kingdom 9 employees Venture round Total: $3.45M Biotechnology, Health Care +1

General Information

Company Name PneumaCare Ltd
Founded Year 2009
Location United Kingdom United Kingdom
Founders / Decision Makers
Team member
Employees 9
Industries Biotechnology, Health Care, VR/AR
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with PneumaCare Ltd. To contact PneumaCare Ltd, visit pneumacare.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PneumaCare Ltd compare?

A PDF of PneumaCare Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PneumaCare Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PneumaCare Ltd

PneumaCare Ltd is a biotechnology startup based in Cambridge, UK, and is a pioneer in Structured Light Plethysmography (SLP) technology. The company provides clinicians with revolutionary non-contact respiratory monitoring systems through its Thora-3Di® product family. This technology offers richer information on a broader patient population without the need for direct contact, reducing the risk of infection and instrument running costs. PneumaCare®'s proprietary SLP technology has diverse applications, including in clinics, pre- and post-operative assessments, drug testing, and device development, with potential expansion into home care, neonatal, critical care, and rehabilitation applications. In 2011, PneumaCare® received recognition, winning the overall Best Business Proposition and the Best Business Proposition in the Respiratory Category at the 2011 Medical Futures Innovations Awards. The company has obtained CE mark approval for its lead product, Thora-3Di®, and has appointed European distributors. Additionally, the company has applied for FDA approval. PneumaCare® received a £1.00M Venture Round investment on 30 October 2013, with investment from Cambridge Angels, Charterhouse Capital Partners, Cambridge Capital Group, Sud Investments, and Torteval Investments. This investment signifies confidence in PneumaCare®'s innovative approach to respiratory diagnostics and monitoring, as well as its potential for further growth and impact in the healthcare industry.

Business keywords: Respiratory diagnostic, 3D imaging technology, Non-contact assessments, Medical devices, CE mark approval, FDA approval, University of Cambridge, Clinical applications, PneumaScan, PneumaCare, Structured Light Plethysmography, Monitoring systems, Patient assessment, Innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £1.00M 5
Charterhouse Capital Partners Cambridge Capital Group
Charterhouse Capital Partners, Cambridge Capital Group +3
30 Oct 2013
Venture Round £2.00M 4
Cambridge Capital Group
Cambridge Capital Group, University of Cambridge Enterprise +2
02 Aug 2011
Angel Round £100.00K -
01 Aug 2010
Grant £250.00K 1
East of England Development Agency
East of England Development Agency
01 Mar 2010
Funding Round Undisclosed 1
Ward Hills
01 Aug 2009
Grant £48.00K 1
Ministry of Defence - UK
01 Jun 2009
Seed Round Undisclosed -
01 Feb 2009
Grant £50.00K 1
East of England Development Agency
East of England Development Agency
01 Feb 2009

PneumaCare Ltd Alternatives & Competitors

View All Alternatives
PneumaCare Ltd vs
iTind
iTind Israel

Reshaping BPH Treatment!

4 employees
Biotechnology, Health Care
PneumaCare Ltd vs
Oxford Endovascular Ltd.
Oxford Endovascular Ltd. United Kingdom

Saving Lives Treating Brain Aneurysms - 'Origami Engineering' for the Brain

Series A
6 employees
Biotechnology, Health Care
PneumaCare Ltd vs
Ablation Frontiers
Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF techno...

Series C
Biopharma, Biotechnology
View all alternatives

FAQ About PneumaCare Ltd

Pioneers of the technology – Structured Light Plethysmography (SLP)
PneumaCare Ltd was founded in 2009.
PneumaCare Ltd is headquartered in United Kingdom.
PneumaCare Ltd operates in Biotechnology, Health Care and VR/AR. Its work centres on Respiratory diagnostic, 3D imaging technology, Non-contact assessments and Medical devices.
PneumaCare Ltd has approximately 9 employees.
PneumaCare Ltd has completed 8 funding rounds, raising a total of $3.45M. The latest funding stage is Venture round.
Top alternatives and competitors to PneumaCare Ltd include iTind, Oxford Endovascular Ltd., Ablation Frontiers, Ceribell │ AI-Powered Point-of-Care EEG, MobileODT. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PneumaCare Ltd and iTind are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PneumaCare Ltd, https://bouncewatch.com/company/pneumacare-ltd, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout